{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:51:54Z","timestamp":1791492714946,"version":"4.3.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148656"],"award-info":[{"award-number":["148656"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["153317"],"award-info":[{"award-number":["153317"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["165967"],"award-info":[{"award-number":["165967"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Huntington\u2019s disease (HD) is an inherited autosomal dominant neurodegenerative disorder that leads to progressive motor and cognitive impairment. There are currently no available disease modifying treatments for HD patients. We have previously shown that pharmacological blockade of metabotropic glutamate receptor 5 (mGluR5) signaling rescues motor deficits, improves cognitive impairments and mitigates HD neuropathology in male zQ175 HD mice. Mounting evidence indicates that sex may influence HD progression and we have recently reported a sex-specific pathological mGluR5 signaling in Alzheimer\u2019s disease (AD) mice. Here, we compared the outcomes of treatment with the mGluR5 negative allosteric modulator CTEP (2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine) in both male and female symptomatic zQ175 mice. We found that female zQ175 mice required a longer treatment duration with CTEP than male mice to show improvement in their rotarod performance. Unlike males, chronic CTEP treatment did not improve the grip strength nor reverse the cognitive decline of female zQ175 mice. However, CTEP reduced the number of huntingtin aggregates, improved neuronal survival and decreased microglia activation in the striatum of both male and female zQ175 mice. Together, our results indicate that mGluR5 antagonism can reduce HD neuropathology in both male and female zQ175 HD mice, but sex has a clear impact on the efficacy of the treatment and must be taken into consideration for future HD drug development.<\/jats:p>","DOI":"10.3389\/fnmol.2022.801757","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:41:52Z","timestamp":1643780512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington\u2019s Mice"],"prefix":"10.3389","volume":"15","author":[{"given":"Si Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tash-Lynn L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled S.","family":"Abd-Elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S. G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eabd2494","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner.","volume":"13","author":"Abd-Elrahman","year":"","journal-title":"Sci. Signal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","article-title":"mGluR5 contribution to neuropathology in Alzheimer mice is disease stage-dependent.","volume":"3","author":"Abd-Elrahman","year":"","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-019-0456-1","article-title":"Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington\u2019s pathology in zQ 175 mice.","volume":"12","author":"Abd-Elrahman","year":"2019","journal-title":"Mol. Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","article-title":"Noncanonical metabotropic glutamate receptor 5 signaling in Alzheimer\u2019s disease.","volume":"62","author":"Abd-Elrahman","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"eaan6387","DOI":"10.1126\/scisignal.aan6387","article-title":"mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease.","volume":"10","author":"Abd-Elrahman","year":"2017","journal-title":"Sci. Signal."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer\u2019s disease mouse models.","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol. Brain"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15750","article-title":"A M1 muscarinic acetylcholine receptor positive allosteric modulator improves pathology and cognitive deficits in female APPswe\/PSEN1\u0394E9 mice.","author":"Abd-Elrahman","year":"","journal-title":"Br. J. Pharmacol. [Online ahead of print]"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210916102638","article-title":"The role of neuroglial metabotropic glutamate receptors in Alzheimer\u2019s disease.","author":"Abd-Elrahman","year":"","journal-title":"Curr. Neuropharmacol. [Online ahead of print]"},{"key":"B9","doi-asserted-by":"publisher","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin.","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease.","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/j.1471-4159.1999.721671.x","article-title":"Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia.","volume":"72","author":"Biber","year":"1999","journal-title":"J. Neurochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrn2335","article-title":"The hippocampus and memory: insights from spatial processing.","volume":"9","author":"Bird","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease.","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington\u2019s disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.","volume":"17","author":"Bode","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2017.09.026","article-title":"Sex-dependent behavioral impairments in the HdhQ350\/+ mouse line.","volume":"337","author":"Cao","year":"2018","journal-title":"Behav. Brain Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuint.2019.03.020","article-title":"Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation.","volume":"126","author":"Carvalho","year":"2019","journal-title":"Neurochem. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-020-00657-7","article-title":"mGluR5 regulates REST\/NRSF signaling through N-cadherin\/\u03b2-catenin complex in Huntington\u2019s disease.","volume":"13","author":"de Souza","year":"2020","journal-title":"Mol. Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington\u2019s disease.","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.410390120","article-title":"Relationship between trinucliotide repeats and neuropathological changes in Huntington\u2019s diease.","volume":"39","author":"Furtado","year":"1996","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.neuroscience.2010.08.012","article-title":"Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons.","volume":"170","author":"Grove-Strawser","year":"2010","journal-title":"Neuroscience"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGluR5 inhibition prevents cognitive impairment and reduces pathogenesis in an Alzheimer disease mouse model.","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease.","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0169-328x(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1.","volume":"57","author":"Ito","year":"1998","journal-title":"Mol. Brain Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","article-title":"Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.","volume":"19","author":"Kim","year":"1999","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"crossref","first-page":"107605","DOI":"10.1016\/j.celrep.2020.107605","article-title":"Defining the homo-and heterodimerization propensities of metabotropic glutamate receptors.","volume":"31","author":"Lee","year":"2020","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00415-004-0461-9","article-title":"Cognitive changes in patients with Huntington\u2019s disease (HD) and asymptomatic carriers of the HD mutation.","volume":"251","author":"Lemiere","year":"2004","journal-title":"J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"JET","DOI":"10.1124\/jpet.121.000735","article-title":"mGluR2\/3 activation improves motor performance and reduces pathology in heterozygous zQ175 Huntington\u2019s disease mice.","volume":"2021","author":"Li","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes.","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","article-title":"Huntingtons disease.","volume":"315","author":"Martin","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175.","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1111\/bph.15515","article-title":"Blocking metabotrobic glutamate receptor 5 by the negative allosteric modulator CTEP improves disease course of ALS in SOD1G93A mice","volume":"178","author":"Milanese","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1023\/a:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation.","volume":"29","author":"Morton","year":"2000","journal-title":"J. Neurocytol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study.","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease.","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1124\/pr.57.3.1","article-title":"Heterodimerization of g protein-coupled receptors: specificity and functional significance.","volume":"57","author":"Prinster","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/mds.23606","article-title":"Coordination of fingertip forces during precision grip in premanifest Huntington\u2019s disease.","volume":"26","author":"Rao","year":"2011","journal-title":"Mov. Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington\u2019s disease.","volume":"23","author":"Ribeiro","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","article-title":"Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington\u2019s disease.","volume":"30","author":"Ribeiro","year":"2010","journal-title":"J. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-010-8153-1","article-title":"Huntington\u2019s disease and Group I metabotropic glutamate receptors.","volume":"43","author":"Ribeiro","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.phrs.2016.11.013","article-title":"Metabotropic glutamate receptors and neurodegenerative diseases.","volume":"115","author":"Ribeiro","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3.","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/jmg.28.8.515","article-title":"Age at onset in Huntington\u2019s disease: effect of line of inheritance and patient\u2019s sex.","volume":"28","author":"Roos","year":"1991","journal-title":"J. Med. Genet."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review.","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1212\/01.wnl.0000065888.88988.6e","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-c","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neurosci. Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease.","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease.","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease.","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers.","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","article-title":"Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease.","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/hipo.20658","article-title":"Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington\u2019s disease mice.","volume":"20","author":"Zajac","year":"2010","journal-title":"Hippocampus"},{"key":"B54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease.","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Related Disord."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.801757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:42:03Z","timestamp":1643780523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.801757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":54,"alternative-id":["10.3389\/fnmol.2022.801757"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2022.801757","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"article-number":"801757"}}